FTC moves to block DNA sequencer Illumina’s acquisition of PacBio
Illumina has become dominant in next-generation sequencing by building machines that sequenced DNA cheaper and faster than others.
Illumina has become dominant in next-generation sequencing by building machines that sequenced DNA cheaper and faster than others.
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss of revenue once Keytruda…
Summa Health’s experience with Sepsis Watch shows the difficulties in implementing AI in a community hospital.
Health care cybersecurity policy rests on a fundamental misunderstanding of what cybercriminals actually want.
Efforts to eliminate pass-fail grading in medical schools are misguided attempts to undermine the value of a diverse physician workforce, writes a medical student.
Hype around a Microsoft AI agent’s ability to diagnose difficult cases misses the mark and overlooks real innovation, experts say.
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment.
FDA staff are struggling and missing deadlines, and the future consequences could be even more dire.
This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.
Hype around a Microsoft AI agent’s ability to diagnose difficult cases misses the mark and overlooks real innovation, experts say.
When female athletes collapse on the playing field, they are less likely to be resuscitated than men: How gender differences play out in sports medicine.